Skip to main content
Shai Friedland, MD, Gastroenterology, Palo Alto, CA, Stanford Health Care

ShaiFriedlandMD

Gastroenterology Palo Alto, CA

Assistant Professor, Medicine - Gastroenterology & Hepatology, Stanford University Medical Center

Dr. Friedland is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Friedland's full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 1999 - 2002
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1996 - 1999
  • University of California San Diego School of Medicine
    University of California San Diego School of MedicineClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - 2024
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Other

Authored Content

  • Colorectal Cancer Is on the Rise in Young AdultsJune 2018

Press Mentions

  • AI-Assisted Colonoscopy Doesn't Always Improve Adenoma Detection: Study
    AI-Assisted Colonoscopy Doesn't Always Improve Adenoma Detection: StudyMarch 20th, 2023
  • Colorectal Polyps Often Recur After Incomplete Resection
    Colorectal Polyps Often Recur After Incomplete ResectionAugust 9th, 2021
  • CellMax Life and Sebela Pharmaceuticals Enter Strategic Development and Commercialization Partnership for FirstSight™ Blood Test for Detection of Colorectal Cancer and Pre-Cancer
    CellMax Life and Sebela Pharmaceuticals Enter Strategic Development and Commercialization Partnership for FirstSight™ Blood Test for Detection of Colorectal Cancer and Pre-CancerMarch 23rd, 2021
  • Join now to see all

Hospital Affiliations